Modeling the long-term outcomes and costs of HIV antiretroviral therapy using HIV RNA levels: application to a clinical trial. [electronic resource]
Producer: 19990629Description: 499-508 p. digitalISSN:- 0889-2229
- Anti-HIV Agents -- economics
- CD4 Lymphocyte Count
- Clinical Trials as Topic
- Cost-Benefit Analysis
- Costs and Cost Analysis
- HIV Infections -- drug therapy
- HIV Protease Inhibitors -- economics
- HIV-1 -- genetics
- Humans
- Indinavir -- economics
- Lamivudine -- economics
- Models, Biological
- Models, Economic
- Outcome and Process Assessment, Health Care
- RNA, Viral -- blood
- Reverse Transcriptase Inhibitors -- economics
- Time Factors
- Treatment Outcome
- Viral Load
- Zidovudine -- economics
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.